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Abstract
Background: Up to 80% of United States (U.S.) citizens will contract the human papillomavirus
(HPV) at some point in their lives. HPV has the ability to cause multiple types of cancer,
including cervical, vulvar, vaginal, penile, anal, and oropharyngeal. The most recent HPV
vaccine is effective against nine strains of the virus, which account for most cases of cancer and
genital warts caused by HPV. Parents are a key component in reaching Healthy People 2030’s
goal to have 80% of all adolescents in the U.S. completely vaccinated against HPV. Objective:
The purpose of this systematic review was to determine if parental education regarding the
implications associated with contracting an HPV infection and the development of cancer and
knowledge of the impact of the HPV vaccine on HPV infection rates (and thus cancer
prevention) could increase adolescent vaccination initiation and completion rates in the U.S.
Results: Research does not strongly support education as a sole intervention to achieve Healthy
People 2030’s goal. Findings: Multiple interventions are likely necessary to impact HPV
infection and vaccination rates in adolescents, including parental education, policy change,
public health campaigns, and public health interventions such as school-based vaccination
clinics.
Keywords: Vaccine hesitancy, vaccine refusal, vaccine compliance, vaccine uptake, HPV
vaccine, HPV vaccination, human papilloma virus vaccine, papillomavirus, education, teaching,
instruction, parents, caregivers, mother, father, parent, United States of America, America, US,
USA, teen, adolescent, preteen
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Parental Education on Implications of HPV Infection in Their Adolescent Children:
Can This Increase HPV Vaccination Initiation and Completion Rates?
Human papillomavirus (HPV) is the most common sexually transmitted infection in the
United States (U.S.), with up to 80% of citizens contracting this infection during their lifetime
(Niccolai & Hansen, 2015). Up to 50% of infected individuals contracted HPV during their first
sexual encounter (Niccolai & Hansen, 2015). More than 32% of female adolescents age 14 to 19
years old have contracted HPV (Dorell et al., 2014). This infection is well known to cause
multiple types of cancer, including cancer of the cervix, vulva, vagina, anus, penis, and
oropharynx (Brewer et al., 2020; Lee et al., 2016; Lu et al., 2015; Schnaith et al., 2018; Thomas
et al., 2012). Seventy percent of the world’s cervical cancer cases are caused by HPV strains 16
and 18, both of which are vaccine preventable (Lee et al., 2016). Brewer et al. (2020) assert there
are 42,000 new cases of cancer diagnosed annually in the U.S. per year that can be attributed to
HPV. Oropharyngeal squamous cell carcinoma is now the leading HPV associated cancer in the
U.S. (Schnaith et al., 2018). HPV can also cause non-cancerous diseases, such as genital warts
(Moss et al., 2016a). HPV can also be asymptomatic, allowing individuals to unknowingly
spread this infection (Lu et al., 2015; Niccolai & Hansen, 2015).
The HPV vaccine became available in the United States in 2006, with initial
recommendations solely for girls. Recommendations for boys were added in 2010 (Thomas et
al., 2012). The nine-valent HPV vaccine (Gardasil 9) is the most recent HPV vaccine, approved
for use in 2014 (Lee et al., 2016). This vaccine protects the individual from strains of HPV that
cause 95% of genital warts and 90 to 95% of anogenital cancers (Brewer et al., 2020). Current
guidelines recommend vaccinating against HPV at 11 to 12 years of age, as the vaccine is most
beneficial if used before sexual debut (Dela Cruz et al., 2016; Litton et al., 2011; Moss et al.,
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2016a; Victory et al., 2019). If greater than 80% of U.S. adolescents become fully vaccinated
against HPV, it is estimated that 56 to 86% of abnormal Papanicolaou tests, cervical cancer, and
anal cancer could be prevented and genital warts would become nearly eradicated (Brewer et al.,
2020).
Despite the prevalence of HPV-related cancers in the United States, HPV vaccination
rates have failed to meet Healthy People 2020’s goal of 80% of adolescents completing the
vaccine series (Healthy People, 2020; Kornides et al., 2018). Only 49.5% of female and 37.5%
of male adolescents age 13 to 17-years-old have completed the HPV vaccine series (Schnaith et
al., 2018; Victory et al., 2019). Looking at HPV vaccination rates from a global perspective,
developed countries like Australia, England and Denmark report that more than 70% of their
adolescent populations have completed the HPV vaccine series (Niccolai & Hansen, 2015). If the
U.S. could meet the goal of fully vaccinating 80% of adolescents against HPV, an estimated
53,000 cases of lifetime cervical cancer diagnoses could be prevented (Victory et al., 2019).
Background
Phenomenon of Interest
The focus of this paper is to identify how parental education regarding the long-term
health outcomes surrounding contracting an HPV infection impact adolescent vaccine uptake.
Current efforts have failed to meet Healthy People 2020’s goal for 80% of adolescent males and
females to complete the HPV vaccination series (Healthy People, 2020). Healthy People 2030 is
repeating this goal since the United States fell short of achieving the 2020 HPV vaccination
goals (Healthy People 2030, n.d.). Patients under the age of 18 in the U.S. must have parental
consent to get vaccinated. Thus, gaining parental support of the HPV vaccine is a key step in
reaching Healthy People 2030’s goal.
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Clinical Question
In light of the U.S. public health goal of increasing HPV vaccination rates in the U.S., the
following clinical question was developed. Does focused parental education regarding HPV and
its role in cancer development impact HPV vaccine uptake in adolescents (age 9 to 18 years of
age)?
Significance for Advanced Practice
Nurses have historically been among the most trusted professions in the United States
(Moss et al., 2016a). Nurse practitioners are in a position to impact parental decision making
regarding the HPV vaccine and their adolescent children. Patient education is a fundamental
aspect of nursing. Many studies in this literature review identify lack of education as a barrier to
the HPV vaccine uptake. Other studies also found that parental education increases acceptance of
the vaccine (Niccolai & Hansen, 2015; Thomas et al., 2012; Victory et al., 2019). Nurse
practitioners have an opportunity to initiate conversation about HPV and the vaccine, which
gives parents a chance to ask questions and nurse practitioners a chance to clarify misperceptions
about the vaccine. Understanding the role parental knowledge plays in initiating and completing
the HPV vaccine series is critical for advanced practice providers.
Nurse practitioners as a profession have expanded access to healthcare in the U.S.,
especially for individuals in rural and underserved communities. Rural communities historically
have had low rates of HPV vaccination in both male and female adolescents (Thomas et al.,
2012). Underserved communities in the U.S. have higher rates of HPV associated cancers than
the general population. For example, Southeast Asian American females have the highest rate of
cervical cancer of all ethnic groups (Lee et al., 2016). Geographic disparities in HPV vaccine
uptake also exist across the country, with the South and rural communities having lower rates of
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HPV vaccination (Moss et al., 2016a). As an example, the Rio Grande Valley in Texas is
geographically rural, with its residents more likely to be of Hispanic descent and to experience
economic disadvantages, low health literacy, less education, and less access to medical care
(Victory et al., 2019). Nurse practitioners have the ability to increase access and encourage HPV
vaccination in all adolescents, promoting health within their communities and the nation as a
whole (Fenton et al., 2017).
Methods
Search Strategies and Data Abstraction
A thorough systematic literature review was conducted between the dates of 11/13/2020
and 1/21/2021 using CINAHL, PubMed, and Cochrane Database. Information covered in these
databases included nursing and allied health, healthcare, evidence-based medicine, nursing,
dentistry, veterinary medicine, health care systems, and preclinical sciences. Table 1 (see
Appendix) reviews restrictions added to the literature search. Keyword combinations were used
to further narrow research articles pertaining to the area of interest. Key words used for this
process included vaccine hesitancy, vaccine refusal, vaccine compliance, vaccine uptake, HPV
vaccine, HPV vaccination, human papilloma virus vaccine, papillomavirus, education, teaching,
instruction, parents, caregivers, mother, father, parent, United States of America, America, US,
USA, teen, adolescent, and preteen. Table 2 (see Appendix) further addresses keyword
combinations used for this review. Number of articles matching keywords and keyword
combinations were also included in Table 2 (see Appendix). Searches that retrieved 100 or fewer
articles triggered a review of article titles and abstracts. Complete studies were read if titles and
abstracts pertained to the research question. Ninety studies were reviewed, and 33 articles met all
inclusion criteria.
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Inclusion and Exclusion Criteria
Articles utilized in this review included parents of U.S. adolescents ages 9 through 18
years of age; parental education on HPV, HPV’s role in cancer development, and the HPV
vaccine; full text articles written in the English language; peer reviewed; recommendations on
how providers should approach vaccine hesitancy; and recommendations for parental education.
Studies that included a discussion surrounding state vaccination policies and HPV vaccination
rates were also included for review. Studies were excluded if education was only directed
towards adolescents; parents of children over age 18 years of age; or included participants from
countries outside of the U.S. Table 3 addresses further inclusion and exclusion criteria (see
Appendix).
Literature Review
The literature review process revealed multiple types of research studies to include in this
paper. This section will discuss findings from the studies included for analysis after completion
of the systematic review.
Study Characteristics
Types of research
Research designs included in this study are clinical reports, cohort studies, cross sectional
studies, qualitative studies, systematic reviews (including randomized and non-randomized
designs), quasi-experimental studies, expert opinions, randomized trials, and non-randomized
control trials. Levels of evidence from these studies ranged from level I through level VII. Table
4 (see Appendix) addresses further insights into research articles included in this systematic
review.
Populations studied
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Populations studied included mothers, fathers, caregivers and guardians of adolescents
ranging from nine to 18 years of age; individuals belonging to the Caucasian, Hispanic,
multicultural Hawaiian, African American, Cambodian American, and Native American (Hopi)
races; along with healthcare workers and medical students.
Interventions
Multiple methods of communication were utilized to provide education on HPV, the
HPV vaccine, and health outcomes associated with HPV infection. Written educational
information was disseminated via handouts (ex. Bright Futures), flyers, posters, postcards,
pamphlets, fact sheets, booklets, and vaccine information available in the clinic. Public
communications, including radio and billboard advertisements, spread information to
communities. Digital education resources included educational images posted on public social
media accounts, website advertising, informational web pages, and DVD’s. Verbal educational
interventions included physician-led presentations to parents, adolescents, school staff, school
nurses, family and pediatric primary providers, medical school students, and mother/daughter
dyads. In one study, health professionals provided educational information to parents of
adolescents over the telephone. Some studies addressed education on HPV for multidisciplinary
clinic employees.
Some studies included multiple interventions, aside from parental education, aimed at
increasing HPV vaccination rates in adolescents. Such interventions included motivational
interviewing, patient prompts (ex. reminder magnets, text messages, or phone calls for next
dose), role playing simulations with a vaccine-hesitant parent, provider prompts (ex. EMR
reminder message), schools as an alternative vaccination site, school vaccine requirements,
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parental interviews, questionnaires, surveys, provider vaccine recommendation, and education
for providers on best practices for recommending the vaccine.
Research Synthesis
Education
Healthcare provider role
Patient education is a core component of a health care provider’s role. Research supports
the notion that parents prefer to receive education about HPV and their child’s health directly
from their provider, rather than alternate sources (Dela Cruz et al., 2016; Litton et al., 2011).
Education should highlight the vaccine’s ability to prevent certain types of cancers, as well as
dispelling common myths such as encouraging premarital and unprotected sex (Brewer et al.,
2020; Suryadevara et al., 2019).
Public health campaigns
Brewer et al. (2020) utilized a “Boot Camp Translation” to create messages for the local
public in Mesa County and the Denver metro area, aiming to increase adolescent uptake of the
HPV vaccine. HPV messaging was dispersed among the communities with social media
messages, posters, and educational materials provided in pediatric primary care clinics (Brewer
et al., 2020). Educational messages and materials were tailored to the specific community the
researchers targeted, such as individuals with low health literacy in the Denver metro area.
Brewer et al.’s (2020) study was published very recently, so researchers are continuing to
monitor the campaign’s outcome on HPV vaccination rates. However, researchers identified that
different communities preferred campaign messages that emphasized different aspects of the
vaccine (ex. cancer prevention vs. misconceptions) (Brewer et al., 2020). This may be useful
information for future research studies on public health campaigns.
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Educational motivators for adolescents and parents
Studies found in the literature review indicated that parents who were educated about the
HPV vaccine by their healthcare provider were more likely to vaccinate their adolescent
daughters than if they did not receive this information (Litton et al., 2011). Highlighting the
vaccine’s ability to prevent certain types of cancers has also shown modest improvement in
adolescent HPV vaccination rates (Suryadevara et al., 2019). Suryadevara et al. (2019) studied
the impact of educating healthcare providers and staff, parents, and adolescents on cancer
prevention associated with the HPV vaccine. The study included multiple clinic sites, which
yielded a 12-20% increase in series completion rate in pre-teens (11 to 12 years old), and an
increase of 7-23% in teens (13 to 18 years old) (Suryadevara et al., 2019).
Despite the many educational intervention studies that exist, only one study was found
that met the Healthy People 2020 goal (80% HPV vaccination completion rate post-intervention)
using a parental educational intervention (Winer et al., 2016). The Winer et al. (2016) research
team studied effects of a Hopi Native American mother-daughter educational intervention.
Mother-daughter dyads were invited to a dinner featuring an educational presentation, with the
intervention group’s focusing on HPV. Winer et al. (2016) found that Hopi mothers who learned
about HPV were significantly more likely to initiate and complete the HPV vaccine series for
their daughters than mothers whose educational presentation was on juvenile diabetes (the
study’s control group). While only 20% of the intervention group’s females age 11 to 12 years
had completed the vaccine series, 80% of 13 to 17-year-old females had completed the HPV
vaccine series upon recheck.
Fu et al. (2014) completed a systematic review of educational interventions aiming to
increase acceptance of the HPV vaccine. Most studies did not find a dramatic increase in
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adolescent HPV vaccination rates (Fu et al., 2014). Additionally, Fu et al. (2014) found that
interventional literature does not accurately represent the United States’ population. Most studies
only included literate individuals who had attained a level of higher education. Thus, it is
difficult to attain an accurate understanding of how educational interventions work across more
diverse populations based off existing literature.
Factors Implicated in Parental Acceptance of the HPV Vaccine
Provider recommendation plays a large role in parental HPV vaccine acceptance,
regardless of the family’s sociodemographic group or race (Dela Cruz et al., 2016; Litton et al.,
2011; Sanderson et al., 2017; Schnaith et al., 2019; Victory et al., 2019). Other associated factors
include parental trust in the provider, positive parental attitude and intention to vaccinate, use of
preventive healthcare, patient’s mother (not both parents) decides on vaccination, insurance
coverage of the HPV vaccine, increased parental knowledge of HPV and the vaccine, parental
history of HPV risk, geographic region (rural vs. urban), age of the child, and parent gender
(fathers are less likely to vaccinate daughters) (Fu et al., 2014; Victory et al., 2019).
Factors Implicated in Parental Delay or Refusal of the HPV Vaccine
Parents play a large role in their children’s immunizations, including the HPV vaccine.
Up to 36% of parents refuse this vaccine for their children (Kornides et al., 2018). Research
indicates there are a multitude of factors that cause parents to delay or refuse vaccinating their
adolescents against HPV infection. Factors identified in this literature review included low
parental knowledge about the vaccine, concerns about the vaccine’s safety and efficacy, belief
that the vaccine encourages premarital sex, view the vaccine is unnecessary, believe their child is
not sexually active, lack of or low provider recommendation, negative media coverage, and
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barriers to accessing the vaccine (ex. cost, inconvenience) (Brueggmann et al., 2015; Dorell et
al., 2014; Kinder, 2016; Kirchhoff et al., 2019; Schnaith et al., 2018; Victory et al., 2019).
Males and the HPV Vaccine
Even though HPV vaccination rates in adolescent males has significantly increased since
the vaccine became available to boys, adolescent male HPV vaccination rates remain low (Lu et
al., 2015). Lu et al. (2015) found the most common reason that parents did not vaccinate their
male child was because they felt their provider did not recommend it. Other reasons for not
vaccinating sons included parental lack of knowledge on the HPV vaccine, concern for safety,
personal belief that it was not necessary, and that their son was not yet sexually active (Lu et al.,
2015). This study also found that white non-Hispanic males were significantly less likely to be
vaccinated than Hispanic or non-Hispanic black male adolescents (Lu et al., 2015).
Mayer et al. (2013) studied parental and son beliefs about the HPV vaccine and sexual
disinhibition. Both parents and sons felt that the adolescent male and his girlfriend would feel
safer taking risks after vaccination (Mayer et al., 2013). Parental characteristics that were
associated with increased likelihood to vaccinate their child included having a daughter who was
vaccinated against HPV, parents that did not have a daughter, not having a strong belief that the
vaccine would cause sexual disinhibition, and having liberal political views (Mayer et al., 2015).
Parents with conservative political views were more likely to believe the HPV vaccine would
cause sexual disinhibition, and potentially deter the parent from vaccinating their child (Mayer et
al., 2015). Boys in this study who thought their peers approved of the vaccine were more likely
to believe the vaccine would produce sexual disinhibition and did not view this negatively
(Mayer et al., 2015).
Provider Persistence and Communication with Parents
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How healthcare providers communicate education on the HPV vaccine is just as
important as the education itself. Kornides et al. (2018) found that parents who reported they
were highly satisfied or moderately satisfied with provider communication were more likely to
vaccinate their adolescents against HPV than parents who reported low levels of satisfaction with
provider communication. Parents were more satisfied with their provider’s communication if
discussions were easy to understand, there was a clear recommendation to vaccinate against
HPV, they were told the number of doses required for the adolescent, and allowed parents to ask
questions (Kornides et al., 2018).
Additionally, providers should not immediately acquiesce if parents seem hesitant to
vaccinate their adolescent. Many parents who are not sure if they want to vaccinate their child
against HPV may initially respond with hesitancy, such as a question (Shay et al., 2018).
However, Shay et al. (2018) found that when the provider persisted, such as providing an
explanation on benefits of the vaccine or consequences of not vaccinating, parents who were
initially hesitant ended up vaccinating their child at the same appointment. Shay et al. (2018)
also found that when providers did not persist against initial parental hesitation, no adolescents
received the HPV vaccine that day. To further support persistence rather than acquiescence, a
persistent response took less than 4 minutes to discuss while acquiescent responses took greater
than 5 minutes (Shay et al., 2018). With busy provider schedules, a persistent response to
vaccine hesitant parents would save the provider valuable time for other health promoting
opportunities. Clear recommendations, open lines of communication, and persistence should be
used as communication tactics to increase the likelihood of vaccinating the adolescent patient
against HPV.
Cultural Competence and Underserved Populations
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Racial minority communities in the U.S. are disproportionately more likely to have
poorer health outcomes related to HPV infection (Sanderson et al., 2017). Females that have a
low income, are an ethnic minority, or an immigrant have higher cervical cancer rates compared
to the general female population in the U.S. (Dela Cruz et al., 2016). African Americans are a
cultural group that suffers from high rates of cancers caused by HPV (Fu et al., 2018). Due to
barriers to healthcare, even if the African American community achieved high rates of HPV
vaccination, it is estimated that they would continue to have the highest risk of morbidity from
cancers caused by HPV (Fu et al., 2018). Hispanic American women are also more likely to be
diagnosed with and die from cervical cancer than non-Hispanic white females (Brueggmann et
al., 2015; Kaul et al., 2019). This disparity is thought to be related to the Hispanic female
population experiencing high rates of HPV infection, lack of knowledge that HPV can cause
cancer, lower health literacy levels, decreased healthcare access, and low rates of screenings and
follow-ups (Brueggmann et al., 2015; Kaul et al., 2019).
In order to improve HPV vaccination uptake in all racial and ethnic communities that are
present in the U.S., parental and patient culture must be included. Fu et al. (2018) found that
common concerns in the African American community, such as fear of medical experimentation
or close social contacts with this concern, were powerful enough to cause parents to not
vaccinate their adolescents against HPV. Educational interventions should consider social
influences unique to the parent’s culture (Fu et al., 2018).
Providing educational materials that are culturally diverse and represent the racial and
ethnic populations of a clinic’s patient base is also an important aspect of improving HPV
vaccination rates among all races and ethnicities (Brueggmann et al., 2015; Dela Cruz et al.,
2016). Educational material that a culture considers relevant may have a positive influence on a
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parent’s decision to vaccinate their adolescent. Relevance would mean incorporating testimonials
and pictures of individuals from the same race or ethnicity, reflective of the local community’s
population, as well as presenting information in languages besides English (Brueggmann et al.,
2015; Dela Cruz et al., 2016).
Childhood Cancer Survivors
Individuals who have cancer during their childhood are at increased risk for developing
another form of cancer later in life (Kirchhoff et al., 2019). Specifically, female childhood cancer
survivors are 40% more likely to develop cancer from an HPV infection and males are 150%
more likely than non-childhood cancer survivors (Kirchhoff et al., 2019). However, parents of
childhood cancer survivors are less likely than the general population to vaccinate their
adolescent against HPV (Kirchhoff et al., 2019). Parents who spoke with their child’s oncologist
about vaccines and possible side effects were more likely to vaccinate their adolescent against
HPV (Kirchhoff et al., 2019).
Gaps in Literature
This author noted a significant gap in literature regarding educational interventions
aiming to increase adolescent male HPV vaccine series initiation and completion rates.
Adolescent males have significantly lower rates for initiating and completing the HPV vaccine
series. HPV can be spread from males to females and other males, so increasing vaccination rates
in this population could theoretically slow the spread of HPV among the U.S. population. In
addition, many interventional studies focused mainly on non-Hispanic white females. Expanding
studies to focus on parental educational interventions of a culturally and gender diverse
population may shed light on how to reduce health disparities that currently exist in some racial
and ethnic populations. To promote the health of all Americans, efforts to increase HPV vaccine
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initiation and completion rates must include parents of males and females, as well as individuals
from a variety of races and ethnicities.
Discussion
Mixed Results and Clinical Practice
There were conflicting findings with regards to the efficacy of education as a sole
intervention to increase the U.S. adolescent HPV vaccination rates in this literature review. Only
one study among all the studies evaluated regarding parental education impacting vaccination
completion rates met Health People’s 2020 goal (Winer et al., 2016). This is a promising
intervention that deserves more research, both within the Native American population and the
general U.S. population. Until further research using this type of intervention is replicated, it is
difficult to say if the results from this study can be applied to other cultural groups within the
U.S. Overall, educational interventions may have a positive impact on vaccination rates, but the
impact is modest and likely not enough to attain Healthy People’s goal. Reaching the 80%
vaccination goal will likely only be met with a multifaceted approach, with possible policy
intervention.
However, a modest improvement is better than no improvement at all, and healthcare
providers must not underestimate the important role they play in educating their patients and
parents. Providers should always provide education on HPV infection, health implications, and
the vaccine. Vaccinating youth against HPV has the ability to prevent multiple types of cancer,
as well as genital warts, amongst this patient population.
Improving the Adolescent Male Vaccination Rate
A large portion of available literature focuses on adolescent females, or both adolescent
females and males. There are not enough studies available that have focused on interventions
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aimed specifically at increasing adolescent male HPV vaccination completion rates. Only 37.5%
of male adolescents age 13 to 17-years-old have completed the vaccine series, far below Healthy
People’s goal of 80% (Schnaith et al., 2018; Victory et al., 2019). HPV can cause cancer in both
males and females, and infected males are able to transfer this infection to their sexual partners.
Further efforts must be made to increase the adolescent male HPV vaccination rate, which has
the potential to decrease cancer risk among both males and females.
More research is needed to determine what, if any, parental educational interventions can
increase male HPV vaccination rates. However, providers can incorporate findings from existing
literature to identify possible teaching points. For example, reassuring parents that the vaccine
does not cause sexual disinhibition may persuade hesitant parents to vaccinate their son.
Providers should also reinforce the need to use barrier protection with sexual activity to protect
against other forms of sexually transmitted infections.
Unique Adolescent Populations
Certain adolescent populations may benefit from a specialty healthcare provider’s
recommendation supporting the HPV vaccine. Kirchoff et al. (2019) found that parents of
childhood cancer survivors were more likely to vaccinate their adolescent against HPV if their
oncologist recommended it. Though primary care providers should recommend the vaccine,
utilizing the patient’s multidisciplinary care could provide parents with more specific
information on the HPV vaccine and childhood cancer survivors. This could be a worthwhile
effort to increasing adolescent HPV vaccination rates.
Reducing Health Disparities
Unfortunately, health disparities still exist in the U.S. As previously discussed, culture,
race, socioeconomic status, lack of health insurance and other factors are associated with
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increased morbidity and mortality from cancers caused by HPV. While preventing disease
should be a goal for the entire U.S. population, efforts must be especially focused to prevent
disease in populations that are most likely to experience adverse outcomes related to HPV
infections. Strategies to reduce barriers, such as parental education, cost, time, and
transportation, may be effective ways to increase adolescent HPV vaccination rates in
populations most at risk for adverse outcomes. This may require broad public health efforts to
vaccinate the greatest number of adolescents. An example could be increasing access to
vaccinations in public schools. Unfortunately, time, finances, and available health care staff may
exist as barriers to such efforts. Increasing public awareness on the importance of the HPV
vaccine, and gaining the public’s support, may be necessary to advance such public health
efforts.
Implications for Future Practice
Recommendations for Clinical Practice
How the HPV vaccine is offered to families can make a significant difference in parental
acceptance rates. Nurse practitioners should “bundle” the HPV vaccine with other scheduled
vaccines for 11 to 12-year-old patients, like meningococcal and Tdap vaccines (Kinder, 2016;
Victory et al., 2019). Even though most schools do not require the vaccine for entry, providers
should strongly and clearly recommend it and emphasize its ability to prevent certain types of
cancers (Bernstein & Bocchini, 2017; Kinder, 2016; Kornides et al., 2018). The vaccine should
be offered in the same way to both males and females (Victory et al., 2019). Each visit to the
clinic should be viewed as an opportunity to vaccinate against HPV (Bernstein & Bocchini,
2017).
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Having clinic staff hand out educational information may not be enough. Dela Cruz et al.
(2016) found that parents preferred their child’s healthcare provider review the educational hand
out with them. This would be a simple way to guide discussion on the HPV vaccine and provide
pauses for parents to have a chance to ask about any questions or concerns they may have.
How providers communicate information about the HPV vaccine to parents can also
impact a parent’s decision to vaccinate or not vaccinate (Kornides et al., 2018). Providers should
reflect on how they currently present information on the HPV vaccine. Do they clearly give a
strong recommendation to vaccinate male and female adolescents? Do they provide information
that is easy to understand, no matter the parents’ education level? Do they provide enough time
for parents to express concerns and ask questions? If not, the provider must aim to include these
points into their HPV vaccine discussion.
Recommendations for Research
After reviewing the literature, a few themes were identified as areas requiring further
research. It is not clear if parental education alone is enough to provide a significant impact on
adolescent HPV vaccination rates. Some of the literature reviewed found, or hypothesized, that
the sole intervention of parental education increased adolescent HPV vaccination rates (Brewer
et al., 2020; Brueggmann et al., 2016; Ferris et al., 2010; Hansen et al., 2016; Shay et al., 2018;
Suryadevara et al., 2019; Victory et al., 2019; Winer et al., 2016). Other research studies suggest
that multiple interventions are necessary for parents to initiate and complete their adolescent’s
HPV vaccine series (Bernstein & Bocchini Jr., 2017; Dela Cruz et al., 2017; Dorell et al., 2014;
Fu et al., 2014; Kaul et al., 2019; Lee et al., 2016; Moss et al., 2016a; Pasket et al., 2016; Roberts
et al., 2018; Sanderson et al., 2019; Walling et al., 2016). Further research should be completed
to determine if multiple interventions produce a more significant increase in HPV vaccine series
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initiation and completion. Further research is also needed to determine which educational
interventions can increase HPV vaccination rates among culturally diverse populations and
support culturally competent care (Fu et al., 2014).
Winer et al. (2016) achieved an 80% HPV vaccine series completion rate in female
participants age 13 to 17-years-old. This was the only study retrieved from the literature review
that produced results that met Healthy People 2020’s goal. Further research is warranted to
explore if a parent/child dinner with an educational presentation on HPV would produce similar
results with fathers, sons, and individuals from communities outside the Hopi Native American
reservation.
Future research should also focus on the role that provider education plays in adolescent
HPV vaccination rates. Schnaith et al. (2018) utilized education on HPV, health outcomes
associated with infection, and how to communicate with vaccine hesitant parents in a group of
University of Minnesota medical students. Students then utilized this knowledge in simulations
with vaccine hesitant parent scenarios. This study found that the education increased the
students’ confidence in discussing and recommending the HPV vaccine to hesitant parents.
Future research should focus on how providers’ confidence actually impacts adolescent HPV
vaccination rates, and if more programs like this should be integrated into provider education.
Other studies included in this literature review focused on provider education on cancer
prevention, and its impact on vaccination rates (Ferris et al., 2010; Suryadevara et al., 2019).
Further research should be conducted to discover which educational topics and methods of
education delivery have a significant impact on increasing HPV vaccination rates in adolescents.
One article included in this review focused on the adolescent mother’s healthcare status
and its relation to adolescent HPV vaccination rates. Rahman et al. (2013) found there was no
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difference in the intent to vaccinate their adolescent between mothers with a well-woman exam
within the last two years compared to women without a recent exam. However, these researchers
felt a mother’s well-woman exam could be an additional opportunity for providers to advocate
for adolescent HPV immunizations and recommend this as an area for further research.
When caring for patients who have survived childhood cancer, the provider’s education
must include the increased likelihood of cancer development from an HPV infection compared to
a child who has never had cancer. However, there is a lack of research surrounding what
educational information should be included for parents after their child has completed treatment.
Further research is necessary to determine how to best address parents of childhood cancer
survivors (Kirchhoff et al., 2019).
Further research studies are needed to determine the impact large scale public health
messages have on adolescent HPV vaccination series initiation and completion rates (Brewer et
al., 2020). Several studies were underway at the time of publication, yet additional research
should be conducted to evaluate the impact of large scale messaging across the nation. Studies
included in this systematic literature review suggested that education tailored to each parent and
patient, along with including cultural implications, was more effective than a generalized
approach (Fenton et al., 2018; Fu et al., 2014; Thomas et al., 2012; Tomas et al., 2013).
However, further studies on patient-centered and culturally competent care are needed to validate
and demonstrate the actual impact on HPV vaccination rates in adolescents. Future research
should also focus on the impact of culturally competent public health messages and its impact on
adolescent HPV immunization rates.
As previously mentioned, there is a significant gap in the literature investigating how
parental education impacts adolescent male HPV vaccine series initiation and completion rates.
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The significant difference between female and male HPV vaccination rates deserves further
research to identify interventions to meet Healthy People 2030’s goal to have 80% of adolescents
vaccinated for HPV (Healthy People 2030, n.d.). Increasing the rate of HPV vaccine series
completion will work towards meeting Healthy People 2030’s goal to reduce the number of HPV
infections in 20 to 34-year-olds that could be prevented by the nine-valent vaccine (Healthy
People 2030, n.d.).
Recommendations for Continuing Provider Education
To increase parental education about HPV and the HPV vaccine, healthcare providers
must be knowledgeable about this topic and comfortable discussing this with parents and
adolescents. One study focused on an educational intervention given to a group of medical
students at the University of Minnesota (Twin Cities and Duluth locations) (Schnaith et al.,
2018). Students took a survey before and after a video, lecture, and simulation focusing on the
HPV vaccine and how to address hesitancy with parents. After the intervention, medical school
students reported they were more likely to recommend the vaccine overall, more likely to equally
recommend the vaccine to males and females, and felt more comfortable to talk about the HPV
vaccine with vaccine hesitant parents (Schnaith et al., 2018). This model could be reproduced as
a continuing education course for healthcare providers who offer the HPV vaccine in their office.
Similar interventions could be added to healthcare providers’ education curriculums as well, to
increase competency and confidence in discussing HPV and the vaccine even as students.
When recommending the HPV vaccine to parents, the healthcare provider’s message
must strongly and clearly encourage the parents to vaccinate their adolescent (Kornides et al.,
2018; Suryadevara et al., 2019). In addition, the healthcare provider must be educated to allow
enough time for parents to ask any questions they may have (Kornides et al., 2018). Continuing
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education courses or school curriculums must encourage providers to highlight cancer prevention
benefits, include basic information on HPV and its role in cancer development, offering the
vaccine at each clinic appointment, bundling vaccines and presenting them as equally important,
and cover how to approach vaccine hesitant parents (Suryadevara et al., 2019).
Recommendations for Addressing Policy Changes
Current policies
At this time there are no federal vaccine requirements to enroll in public schools across
the U.S. Each state is able to determine its own policies surrounding immunization requirements,
with only Washington D.C., Virginia, and Rhode Island requiring the HPV vaccine for school
entry (North & Niccolai, 2016). The rate of HPV vaccinations in the U.S. is significantly lower
than other school-required vaccines. On average, 63% of girls and 50% of boys had initiated the
HPV vaccine series (Roberts et al., 2018). However, vaccination rates vary significantly between
states. The percentage of girls who had initiated the HPV vaccine series ranged from 48% to
88%, while boys ranged 35% to 81% (Roberts et al., 2018). Rates of series completion were
lower than rates of vaccine series initiation. Roberts et al. (2018) found that states with multiple
policy interventions had higher rates of HPV vaccine uptake. Specifically, the combination of
five policy interventions were associated with the highest HPV vaccine rates in the country.
These interventions included expansion of Medicaid through the Affordable Care Act to decrease
financial barriers to vaccination, permitting pharmacists to vaccinate for HPV in local
pharmacies, vaccine requirement for school entry, mandating sex education classes in schools,
and no state requirements for parental education on HPV (Roberts et al., 2018). Rhode Island,
Washington D.C., and Virginia require the HPV vaccine for school entry, but only Rhode Island
and Washington D.C. have adopted all five of these policies. Even with school entry

24
requirements, Virginia has a low HPV vaccine uptake rate. The state also has an expansive
vaccine exemption policy, which may have undermined the policy’s efforts (Roberts et al.,
2018). Rhode Island has the nation’s highest HPV vaccination rates, which could also be
attributed to their “Vaccinate Before You Graduate” program (Kaul et al., 2019). This program
provides the vaccine in schools and a free service (Kaul et al., 2019). However, school-based
vaccination efforts have not been able to increase vaccination rates to 80%, suggesting that
further research and interventions are necessary to meet Healthy People 2030’s goal (Kaul et al.,
2019).
Addressing Existing Disparity Rates with Policy Adoption
General school vaccination requirements have increased the equity of vaccine coverage
and promoted long term health of children (North & Niccolai, 2016). However, this review
suggests that more than a single policy requiring the HPV vaccine for school entry is necessary
to achieve acceptable vaccination rates (Roberts et al., 2018). Further research is necessary for a
deeper understanding of which policy combinations yield HPV vaccine uptake rates that meet
the Healthy People 2020 goals of 80% of the adolescent population (age 13 to 17 years of age)
completing the series, and how to implement such policies (Roberts et al., 2018). While not an
easy task, this is critical to the public health of young Americans. Disparities currently exist in
vaccination rates between races and ethnicities, as well as geographic locations, which may be
due to a lack of policy surrounding the HPV vaccine series. Hispanic individuals have 66.3% of
females and 54.2% of males vaccinated. African American females have a slightly higher female
vaccination rate at 66.4%, but African American males have a significantly lower vaccination
rate than Hispanic males, at 54.2%. Non-Hispanic white adolescents have consistently lower
vaccination rates, with 56.1% of females vaccinated and only 36.4% of males vaccinated (North
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& Niccolai, 2016). Adolescents living in rural communities are 11% less likely to initiate the
HPV vaccine series (Kaul et al., 2019).
Recommendations for Non-Policy Public Health Interventions
If policies surrounding the HPV vaccine cannot be approved by government officials,
there are non-policy public health interventions that are associated with increased HPV vaccine
uptake found in the literature. The following reviews several key strategies to consider.
Universal School Vaccine Programs
Universal school vaccine programs have been implemented in other high-income
countries with success (North & Niccolai, 2016). Australia is an example of a successful
universal school vaccine program. From 2006 to 2011, the country saw an 89.9% decrease in
anogenital warts in girls age 12 to 17 years old (North & Niccolai, 2016). Australia also saw a
decrease in cervical cancer precursors in vaccinated girls compared to non-vaccinated girls. Even
though not all children were vaccinated, there still appears to be possible benefit to the
population as a whole. Unvaccinated Australian females experienced a 38% decrease in
anogenital warts during this same time period (North & Niccolai, 2016). Other high-income
countries that implemented universal school vaccine programs achieved 70% or greater HPV
vaccine rates, without having school entry vaccine requirements (North & Niccolai, 2016).
School vaccination programs have been trialed in the United States. Kaul et al. (2019)
studied the effect of school based parental education and HPV vaccinations on adolescent
vaccination rates in the rural, largely Hispanic, economically disadvantaged and medically
underserved Rio Grande Valley area of Texas. School staff, healthcare staff, and parents reported
the education on HPV and the vaccine increased their knowledge on this topic. Findings from
this study indicated that school-based education on HPV and the vaccine, as well as providing
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the vaccine in school, can significantly increase vaccine series initiation and completion rates in
rural, underserved communities. Researchers found that schools that provided both education
and the vaccine doubled the initiation and completion rates for the HPV vaccine, compared to
schools who provided education as the only intervention (Kaul et al., 2019). Implementing
education and school-based vaccines could be a more effective way to increase HPV vaccine
series initiation and completion rates in the United States.
Chicago’s Department of Public Health HPV Campaign
Another non-policy public health intervention that yielded increased adolescent HPV
vaccine uptake rates is Chicago’s 2013 to 2014 campaign. The city utilized an $800,000 federal
grant to create a public health campaign, provide reminders, and train 200 clinicians with an aim
to increase HPV vaccine uptake in adolescents (North & Niccolai, 2016). By the end of the
campaign, rates of HPV vaccines increased to 78.1% of females and 64.9% of males (North &
Niccolai, 2016). Based upon current U.S. HPV vaccination rates, it is clear that some sort of
intervention is necessary to improve adolescent HPV vaccine series initiation and completion
rates.
Future Research
Multiple factors interact to impact U.S. adolescent HPV vaccination uptake rates. More
research is needed to determine the role of public policy in adolescent HPV vaccination rates
(North & Niccolai, 2016). Currently it is up to individual states to determine school vaccine
requirements. What policy interventions would be most effective at increasing adolescent HPV
vaccination series initiation and completion? Roberts et al. (2018) recommends further research
exploring the effect of multiple policies on HPV vaccine uptake, rather than implementation of a
single policy. Determining an effective policy combination, and likely combining policy with
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effective public health interventions, must be completed to meet Healthy People 2030’s goal to
achieve 80% of adolescents completing the HPV vaccination series. The health of adolescents
and young adults in the United States depends on this.
Conclusion
A large percentage of the U.S. will contract HPV at some point in their lives. HPV has
the ability to cause multiple types of cancer. The most current HPV vaccine is effective against
nine strains of the virus, which account for most cases of cancer and genital warts that are caused
by HPV. Parents are a key component in reaching Healthy People 2030’s goal to have 80% of all
adolescents completely vaccinated against HPV. However, education as a sole intervention may
not be enough to achieve this goal. Utilizing school-based vaccination programs, public health
campaigns, and public policy may be necessary to meet this goal.
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Table 4
Literature Review of All Studies Included
Citation
Study
Population
Purpose
(N)/ Sample
Size (n)/
Setting(s)
Bernstein, H. H., &
Bocchini Jr, J. A. (2017).
Practical approaches to
optimize adolescent
immunization. Pediatrics,
139(3), e1-e14.

To provide
recommendations
to increase
“adherence to the
universally
recommended
vaccines in the
annual
adolescent
immunization
schedule….”

Adolescents,
parents (“n” not
provided). USA.

Excluded

This was a survey, and did not examine how education on the
HPV vaccine affected vaccine uptake.

Excluded

This was a literature review examining HPV vaccine attitudes and
uptake. It did not examine interventions.

Design/
Level of
Evidence

Variables &
Instruments

Intervention

Findings

Implications

Clinical
report. Level
IV.

Instruments used in
studies included
surveys.

Interventions that
can be used to
overcome vaccine
hesitancy are
provided.
Motivational
interviewing.
Patient prompts
(ex. Bright Futures
hand-outs),
provider prompts.
Reminder/ recall
systems for
patients. Schools
as alternative
vaccination sites,
school vaccination
requirements.

Provider explanation
and recommendation
of vaccines are
essential to
increasing vaccine
uptake rates.
Adolescents should
be included in their
care and given the
opportunity to make
health care choices
to prevent disease.
Different approaches
to different parental
attitudes towards
vaccines are given.
Co-administering the
HPV vaccine with
other vaccines can

Providers should
view every visit as
an opportunity to
vaccinate.
Normalize and
advocate for the
HPV vaccine,
explaining that it
prevents cancer,
and it is safe.
Explain the
vaccine schedule to
parents, that it
requires multiple
doses. Do not
delay vaccinating
until the adolescent
becomes sexually
active.
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Brewer, S. E., Nederveld,
A., & Simpson, M.
(2020). Engaging
communities in preventing
human papillomavirusrelated cancers: Two boot
camp translations,
Colorado, 2017-2018.
Preventing Chronic
Disease, 17, E02.

To create
messages that
appeal to each
unique
community
involved to
increase HPV
vaccination
uptake rates.

Total of 21
participants (11
in Mesa County,
10 in Denver
metro).
Participants were
parents of
children (9-11
years in Mesa
County, 8-13
years in Denver
metro).
Researchers
excluded parents
of young adults
as the vaccine is
most effective in
preteens. Settings
included
the Denver metro
area and Mesa
County (semirural), Colorado.

Cohort study.
Level IV.

Boot Camp
Translation (BCT),
a research process
used to develop
messages that
relate to the
community
members, was used
to create
educational
materials and
messages and a
plan to disperse the
information.

Educational
information was
provided in the
form of flyers,
images
disseminated via
social media
platforms, website
advertisements,
postcards, posters,
informational
websites, and
billboards.

boost HPV vaccine
uptake rates.
Participants in a
semi-rural
community preferred
public health
messages to
highlight the benefit
of protection against
cancer, and to
minimize or remove
statements
explaining that HPV
is a sexually
transmitted disease.
Participants in the
urban community
felt public health
campaigns on HPV
should focus on
correcting
misconceptions on
the vaccine. The
Denver metro cohort
also felt long-term
benefits of cancer
prevention should be
included, and parents
of elementary school
aged children should
be targeted with
information on
increased
effectiveness of the
vaccine at a younger
age. The metro area
cohort recommended
trusted local
community locations
should be used to

This research study
found that
translating BCT to
fit HPV
vaccination
promotion works.
Researchers
support the notion
that public health
campaigns should
target the specific
community they
will be placed in.
This study was
completed on a
small scale. At the
time of
publication,
researchers
planned to
continue studying
the communities to
learn how these
public health
messages impact
HPV vaccine
uptake.
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Brueggmann, D., Opper,
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D., Mishell, D., & Jaque,
J. (2016). Development of
a cost-effective
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promote acceptance of the
HPV vaccination by
Hispanic mothers. Journal
of Community Health,
41(3), 468-475.

Develop a costeffective tool to
increase HPV
vaccination
uptake by
Hispanic
mothers.

418 Hispanic
mothers in
waiting area of
women’s health
clinics. Spanish
speaking
between ages 1865, with at least
one child.

Cross
sectional.
Level III.

Surveys were used
to collect data.

Spanish language
educational
pamphlet that
summarized “the
likelihood of HPV
contraction, its
severe
consequences and
the benefits of the
HPV vaccine in
ten simple
statements.”

Dela Cruz, M., Tsark, J.,
Chen, J., Albright, C., &
Braun, K. (2017). Human
papillomavirus (HPV)
vaccination motivators,
barriers, and brochure
preferences among parents
in multicultural Hawai’i:
A qualitative study.
Journal of Cancer
Education, 32(3), 613621.

“To identify
HPV vaccine
barriers,
motivators, and
brochure
preferences
among parents of
teens in
multicultural
Hawai’i.”

20 parents with
children between
ages 11-18 years.
Multicultural
Hawaii.

Qualitative.
Level III.

Telephone or inperson interviews.

Interviews
gathered data on
parent gender,
race, marital
status, age, city of
residence,
occupation, and
age/gender of their
children. Further
questions asked
about knowledge
of HPV vaccines
in general,
knowledge and
attitude on the
vaccine, physician
recommendation
of the vaccine,
discussions of the
vaccine with
others, health
information
sources, and

disperse the
information.
Level of education
and previous HPV
knowledge did not
predict vaccine
acceptance for
children. Women
who reported good
understanding of
information given
from a credible
professional source
had increased levels
of vaccine
acceptance.
Major themes found
were “physician is
critical in the decision
to vaccinate”, “parental
perception of the
child’s sexual activity
guides the timing of
their willingness to
vaccinate”, “HPV
health education
materials should be
provided and discussed
by the physician”, and
“parents would prefer
an educational
brochure that features
local faces and
testimonials, includes
an immunization chart,
and addresses barriers
to vaccination.”

Educational
interventions
should focus on
common
misconceptions
and gaps in
knowledge.
Written
information should
be available in
appropriate
languages and
should be simple
and easy to
understand.
Educational
materials should be
inclusive of a
variety of
ethnicities.
Providers should
take an active role
in recommending
the HPV vaccine
and should review
educational
materials that their
office provides.
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Dorell, C., Yankey, D.,
Jeyerajah, J., Stokley, S.,
Fisher, A., Markowitz, L.,
& Smith, P. J. (2014).
Delay and refusal of
human papillomavirus
vaccine for girls, national
immunization survey-teen,
2010. Clinical Pediatrics,
53(3), 261-269.

Researchers
reviewed data
given by parents
of girls age 13-17
years old to
identify
prevalence of,
associations
with, and reasons
for refusing or
delaying the
receipt of the
HPV vaccine.

4103 parents of
girls age 13-17
years of age.
*HPV vaccine
was only
recommended for
girls at time of
data collection.

Cross
sectional
study. Level
IV.

Information
extracted from the
2010 National
Immunization
Survey-Teen. The
survey used
telephone calls
(random dialing)
with follow-up
mail surveys.
Providers’ reports
gave data on
vaccination status.

Fenton, A. T., Elliott, M.
N., Schwebel, D. C.,
Berkowitz, Z., Liddon, N.
C., Tortolero, S. R.,
Cuccaro, P. M., Davies, S.
L., & Schuster, M. A.
(2018). Unequal
interactions: Examining
the role of patientcentered care in reducing
inequitable diffusion of a
medical innovation, the
human papillomavirus

The purpose of
this study was to
determine the
role that patient
centered care has
in the role of
HPV vaccine
uptake.

5,147 adolescents
(5th-10th grade)
and their parents/
primary
caregivers.
Settings in the
Birmingham
(AL), Los
Angeles (CA),
and Houston
(TX)
metropolitan
areas.

Cohort study.
Level IV.

Healthy Passages
(longitudinal
survey regarding
health-related
behaviors).
Computer and
audio-computer
assisted interviews
in English and
Spanish.
Dependent
variables included
provider

feedback on 3
HPV educational
brochures (which
focused on parent
education on HPV
vaccine).
None, this was a
review of data.

Surveys were
completed on
initial contact,
with follow up
surveys at 2 and 5
years later (7th and
10th grades).
Interviews.

HPV vaccination rates
are lower than other
scheduled vaccination
rates in the US. Girls
with parents of higher
household incomes,
were non-Hispanic
white, and had a
mother with a higher
education level were
more likely to delay or
refuse the HPV
vaccine. Top concerns
with the vaccine
included were possible
long-term health
problems from the
vaccine, concerns if the
vaccine is effective,
and parents’ beliefs
that their daughters do
not need the vaccine.

Researchers found
that patient centered
care contributes to
disparity in the
diffusion of medical
resources, including
the HPV vaccine.
They found some
patient groups are
less likely to have
the HPV vaccine
recommended to

Educating parents
on HPV vaccine
safety and benefits
can increase
vaccination rates.
Providers should
explore parents’
reasons for
delaying or
refusing the
vaccine, listen to
concerns, and
identify/ help with
barriers that may
prevent
vaccination.
Education from
multiple sources
may be more
effective than from
the provider alone.
Authors
recommend further
research on this
topic. Researchers
advocate for the
implementation of
patient centered
care for all
patients, and that
all patients/ parents
should have the
HPV vaccine
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(HPV) vaccine. Social
Science & Medicine, 200,
238-248.

Ferris, D., Horn, L., &
Waller, J. L. (2010).
Parental acceptance of a
mandatory human
papillomavirus (HPV)
vaccination program.
Journal of the American
Board of Family
Medicine, 23(2), 220-229.

The purpose of
this study was to
identify what
influence
parents’
acceptance of a
school-based
HPV vaccine
program that is
required.

325 parents of
children 9-17
years old.
Georgia and
South Carolina.

Cross
sectional
study. Level
IV.

Fu, L. Y., Bonhomme, L.
A., Cooper, S. C., Joseph,
J. G., & Zimet, G. D.
(2014). Educational
interventions to increase
HPV vaccination
acceptance: A systematic
review. Vaccine, 17(7),
1901-1920.

Review and
evaluate
literature for
evidence of
educational
intervention to
increase HPV
vaccine uptake,
intention, or
attitude.

7 studies tested
efficacy of
parental
educational
intervention, 8
with adolescents
or young adults,
and 18 compared
efficacy of
different message
frames of an

Systematic
review.
Studies
included
were
randomized
and nonrandomized
designs,
quasiexperimental

recommendation of
the HPV vaccine,
vaccine status of
the adolescent.
Independent
variables included
patient-centered
care, education,
and race/ ethnicity.
Researchers
created a 53question survey.
Variables included
household income,
education level,
personal history of
HPV infection,
race/ ethnicity,
gender (of parent),
age (of parent and
child), type of/ lack
of health insurance,
knowledge of
HPV, perceived
likeliness of child
to contract HPV,
safety concerns
Various
educational
interventions
designed to
increase patient or
parental attitude
and/or knowledge
on the HPV
vaccine.

53 question survey
focused on
parental opinions
of HPV, the
vaccine, and a
mandatory HPV
vaccination
program.

Parental education
was provided
through written
information fact
sheets, 1-hour
slide presentation,
or Spanishlanguage radio
advertisement.

them than other
patients.

recommended to
them.

Parents who favored
requiring the HPV
vaccine had a personal
history of HPV, fewer
financial resources,
understood their child’s
risk for contracting
HPV, were interested
in getting the vaccine
for their child, and
understood that the
vaccine can prevent
cervical cancer. Parents
who were most likely
to comply with
mandatory HPV
vaccinations had
children 12-14 years
old and knew the
vaccine would reduce
the risk of genital warts
and cervical cancer.

Parental and health
care provider
education on HPV
and the vaccine
needs to be
improved.
Researchers stated
this “should”
increase
vaccination uptake
rate.

In general, this study
did not find strong
evidence for any one
educational
intervention that
could be used for
wide-spread
implementation.

Literature does not
support the use of
one educational
intervention over
any others.
Recommended
further studies to
determine efficacy
of culturally
competent
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Fu, L. Y., Zimet, G. D.,
Latkin, C. A., & Joseph, J.
G. (2019). Social
networks for human
papillomavirus vaccine
advice among African
American parents. Journal
of Adolescent Health,
65(1), 124-129.

The purpose of
this research was
to study HPV
vaccine refusal in
African
American
patients and any
associated social
processes.

Hansen, C. E., Credle, M.,
Shapiro, E. D., &
Niccolai, L. M. (2016). “It
all depends”: A qualitative
study of parents’ views on
human papillomavirus
vaccine for their
adolescents at ages 11-12
years. Journal of Cancer
Education, 31(1), 147152.

The purpose of
this study was to
identify parental
reasoning in
accepting or
refusing the HPV
vaccine for their
11- or 12-yearold child.

educational
intervention
among
adolescents,
young adults,
and/or parents.
353 African
American parents
of 10-12 year old
children who
have not yet had
the HPV vaccine.

designs.
Level III.

educational
interventions.

Crosssectional.
Level IV.

Survey was given
to parents while
they waited for
child’s
appointment.
Variables included
thoughts and
perceptions about
HPV and the
vaccine, social
networks/
community that
parents took advice
from, education
level.

Researchers
reviewed the study
with health care
providers, and also
educated providers
about the best
practices on
immunization
recommendations.

Researchers found
that the study’s
parents’ advice
networks were small
and homogenous.

45 parents/
guardians of
adolescents
(male and
female) in a
primary care
practice in an
urban hospitalbased clinic.

Qualitative
study. Level
VI.

Semi-structured,
face to face
interviews were
completed. Openended questions
were used.
Variables included
parent/ child
demographics,
parental knowledge
on HPV and the
vaccine.

Audio-recorded
interviews were
conducted.

Parents had high
levels of support for
the HPV vaccine if
they understood the
benefits of the
vaccine (i.e.
protection from
genital warts and
cancer). Researchers
found even though
parents who said
they would follow
the recommended
vaccination
schedule, these
parents were hesitant
to actually vaccinate
that day. Some

Some African
American parents
have few members
in their social
network that could
advise them about
the HPV vaccine.
However, the few
individuals they do
count on can be
very influential.
This should be
taken into
consideration with
future educational
interventions.
Health care
providers should
help parents
understand the
advantages of
having their child
vaccinated
according to
schedule, not
waiting until their
child is sexually
active.
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Kaul, S., Do, T. Q. N.,
Hsu, E., Schmeler, K. M.,
Montealegre, J. R., &
Rodriguez, A. M. (2019).
School-based human
papillomavirus
vaccination program for
increasing vaccine uptake
in an underserved area in
Texas. Papillomavirus
Research, 8.

To compare the
efficacy of
communitybased HPVrelated education
and on-site
school-based
vaccination
versus
communitybased education
alone in
increasing HPV
vaccine uptake in
a rural medically
underserved area.

2307 middle
school students
in the Rio
Grande City
Consolidated
Independent
School District
(Texas).

Quasiexperimental.
Level II.

Community based
education was
provided through
community (health
department
community events,
regional
conferences, and
training sessions/
workshops) and
school-based
(vaccination days,
health fairs, backto-school nights,
PTA/school board/
monthly nurse
meetings) events.
School-based
vaccination events
were held in the
nursing office or
conference room
during the school
year.

On-site schoolbased vaccination
program and
physician-led
education
regarding HPV
and HPV vaccines
for parents and
guardians, school
nurses and staff,
and pediatric and
family providers.
CDC’s HPV
related materials
supplemented the
education
provided.

parents thought the
vaccine was not
necessary until their
child became
sexually active
(which they
perceived as late
adolescence).
Researchers found
that fathers were
most opposed to the
vaccination at 11-12
years old. Overall,
most parents did
want to vaccinate
their children.
Prior to the study,
intervention schools
had lower HPV
vaccination initiation
and completion rates
than comparison
schools. After the
study’s intervention,
the intervention
schools had higher
initiation and
completion rates
than comparison
schools.

Increasing HPV
vaccine initiation
and completion
rates may require
more than one type
of intervention.
Combining
community and
school efforts
could be an
effective way to
increase HPV
vaccine uptake in
rural, medically
underserved
communities.
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Kinder, F. D. (2016).
Parental refusal of the
human papillomavirus
vaccine. Journal of
Pediatric Healthcare, 30,
551-557.

This study
identified reasons
parents refused
the HPV vaccine
for their
adolescent
children.

22 parents of 1116-year-old
adolescents in
suburban
Philadelphia, PA.

Mixedmethods.
Level V.

Well-child visit
that included
discussion and
education on
vaccines.

Survey completed
after the well-child
exam.

Parents gave
multiple reasons for
refusing the HPV
vaccine for their
adolescent. Reasons
included perceived
need for further
research, thought the
vaccine was too new,
side effects, don’t
believe it works, lack
of information, or a
father wanted to talk
to the adolescent’s
mother first. No
parents reported
previous education
given by nurse
practitioners, instead
citing information
from family
members or
physicians.

Kornides, M. L., Fontenot,
H. B., McRee, A. L.,
Panozzo, C. A., & Gilkey,
M. B. (2018).
Associations between
parents’ satisfaction with
provider communication
and HPV vaccination
behaviors. Vaccine,
36(19), 2637-2642.

This study was
completed to see
if there is a link
between the
healthcare
provider’s
communication
about the HPV
vaccine and the
parent’s decision
to vaccinate, or
not vaccinate,
their child.

795 parents of
11-17-year-olds
and discussed the
HPV vaccine
with provider at
least one time.

Cross
sectional.
Level IV.

Researchers
created and used
the HPV Vaccine
Communication
Scale (7 questions).
Completed online.
Variables included
demographics,
confidence in the
vaccine, quality of
relationship with
healthcare
provider,

The HPV Vaccine
Communication
completed.

Parent satisfaction of
the healthcare
provider’s
communication
could be an
important
component in the
parent’s HPV
vaccination decision.
They also found that
providers were not
100% clear on their

The HPV vaccine
should be offered
more than once
(i.e. multiple health
care visits) to
given parents time
to learn and think
more about the
vaccine. Nurse
practitioners and
physicians are
perfectly placed to
provide education
to parents.
Education should
focus on safety,
especially cancer
prevention. Allow
parents a chance to
ask questions, and
for providers to
dispel false
information (i.e.
that vaccine
encourages
adolescent sexual
activity).
The HPV Vaccine
Communication
Scale can be used
to help providers
understand what
areas of
communication
they can improve
on. Researchers
also recommend
clearly stating a
recommendation
for the HPV
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Lee, H., Kim, M., Kiang,
P., Shi, L., Tan, K., Chea,
P., Peou, S., & GriggSaito, D. C. (2016).
Factors associated with
HPV vaccination among
Cambodian American
teenagers. Public Health
Nursing, 33(6), 493-501.

Researchers
aimed to
“determine the
HPV vaccine
uptakes among
CA teenagers and
to examine
factors
influencing HPV
vaccine uptakes.”
*CA=
Cambodian
American

130 CA mothers
of adolescent
daughters (ages
12-17 years).
Massachusetts.

Cross
sectional.
Level IV.

Litton, A. G., Desmond,
R. A., Gilliland, J., Huh,
W. K., & Franklin, F. A.
(2011). Factors associated
with intention to vaccinate
a daughter against HPV: A
statewide survey in
Alabama. Journal of
Pediatric and Adolescent
Gynecology, 24(3), 166171.

The purpose of
this study was to
determine any
associations
between medical,
behavioral, and
demographic risk
factors for
accepting the
HPV vaccine of
Alabamans.

403 parents of
daughters age1014 years old.

Cross
sectional.
Level IV.

provider’s
recommendation
quality, parent’s
refusal or delay to
vaccinate, and their
child’s current
vaccination status.
Before starting to
recruit participants,
researchers aimed
to “increase
awareness and
encourage
participation” by
utilizing
commercials on
local Khmer radio
and TV stations,
posters around the
community, and
word of mouth.
“Tell-A-Friend
about Data is
Power”
Telephone survey.
Variables included
demographics,
knowledge, beliefs
around sex and
HPV, waiting time
for appointment

Face to face
interviews (Khmer
or English
language).

Surveys
completed.

recommendation of
the vaccine.

vaccine according
to the CDC’s
vaccination
schedule.

CA girls had higher
HPV vaccination
rates than boys (29%
vs 16%). CA
mothers had low
rates of knowledge
and awareness of
HPV. Data showed
that daughters were
more likely to be
vaccinated if their
mother had a higher
level of English
reading ability, as
well as increased
knowledge and
awareness of HPV.
This study found that
44.6% of female
caregivers were
undecided about
vaccinating their
daughter, and only
16.8% were against
the vaccination.

Improved HPV
vaccine education
and outreach must
be implemented to
increase HPV
vaccine uptake in
the CA
community.

Providers should
understand that
parents who
express hesitancy
to the vaccine are
not necessarily
“anti-HPV
vaccine”. This is
an opportunity to
correct
misperceptions
about the vaccine,
discuss benefits,
and the safety of
the vaccine.
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Lu, P. J., Yankey, D.,
Jeyarajah, J., O’Halloran,
A., Elam-Evans, L. D.,
Smith, P. J., Stokley, S.,
Singleton, J. A., & Dunne,
E. F. (2015). HPV
vaccination coverage of
male adolescents in the
United States. Pediatrics,
136(5), 839-849.

Researchers used
results from the
2013 National
Immunization
Survey-Teen data
to examine HPV
vaccine initiation
and completion
rates of male
adolescents.
They also sought
to identify any
factors that may
predict HPV
vaccination in
this population.

9,554 adolescent
males (age 13-17
years). United
States.

Cohort study.
Level IV.

Telephone survey,
participants
recruited with
random dialing.
Collection of
provider-reported
vaccine records as
survey follow-up.
Variables included
demographics
(parent), number of
physician visits
within the last 12
months, number of
vaccination
providers,
attending 11-12
year well child
visit, type of health
care facility
attended (ex.
Public or private,
STD clinic,
hospital, etc.), and
geographic area of
the United States.

Survey
completion.

Mayer, M. K., Reiter, P.
L., Zucker, R. A., &
Brewer, N. T. (2013).
Parents’ and sons’ beliefs
in sexual disinhibition
after human
papillomavirus
vaccination. Sexually
Transmitted Diseases,
40(10), 822-828.

The purpose of
this study was to
identify
adolescent
males’ and their
parents’ beliefs
about sexual
disinhibition in
males after

547 parents of
adolescent males
(age 15-17
yearss) and their
sons. United
States.

Cross
sectional.
Level IV.

Online surveys
with mult-item
scales. Variables
included
demographics,
geographic region
of the US
(including urban,
rural), political
ideaology,

Online survey
completion.

HPV vaccination
rates for male
adolescents
increased from the
2010 NIS-T survey
but were still low.
Male adolescents
and their parents had
less awareness of the
HPV than female
adolescents and their
parents. This
population needs to
be targeted with
future interventions
aimed at increasing
the HPV vaccine
series uptake and
completion.
Measures should
also be taken to
increase vaccine
coverage in males
that are least likely
to be vaccinated. The
number one barrier
to vaccinating male
adolescents was lack
of provider
recommendation.
Most participants did
not feel that the HPV
vaccine was related
with sexual
disinhibition in
adolescent males.
Researchers noted
that at the time of the
survey the HPV
vaccine was not

Healthcare
providers should
strongly
recommend the
HPV vaccine series
to all adolescent
males and their
parents. Providers
should also inquire
about parental
reasons for
hesitation and
correct
misconceptions.

Providers should
understand that
certain
characteristics,
such as
conservative
political ideology
and Hispanic
ethnicity, are
associated with
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getting the HPV
vaccine.

Moss, J. L., Gilkey, M. B.,
Rimer, B. K., & Brewer,
N. T. (2016a). Disparities
in collaborative patientprovider communication
about human
papillomavirus (HPV)
vaccination. Human
Vaccine
Immunotherapeutics,
12(6), 1476-1483.

Moss, J. L., Reiter, P. L.,
Rimer, B. K., & Brewer,
N. T. (2016b).
Collaborative patientprovider communication
and uptake of adolescent
vaccines. Social Science &
Medicine, 159, 100-107.

Researchers
studied the
National
Immunization
Survey- Teen,
Parental
Attitudes Module
2010, to see if
disparities in
collaborative
communication
“mediated the
relationship
between
demographic
characteristics
and HPV vaccine
initiation.”
Determine how
patient-driven or
provider-driven
communication
styles impact
vaccine uptake.
“Patient”
included parents
in this study.

insurance
coverage, thoughts
on HPV and the
vaccine, provider’s
recommendation.

routinely
recommended for
males, so participant
answers may be
different if the study
is repeated.

4,124 parents of
daughters (ages
13-17 years old).
United States.

Cohort study.
Level IV.

Telephone survey,
participants
recruited with
random dialing.
Collection of
provider-reported
vaccine records as
survey follow-up.
Variables included
demographics
(parent),
geographic region
of the United
States, provider use
(or lack of) of
collaborative
communication.

Survey
completion.

9,194 parents of
adolescents (ages
13-17) who
consented
provider
verification of
vaccine history.
Data was
collected from
the 2010
National
Immunization

Cohort study.
Level IV.

Parents completed
the Parental
Attitudes Model,
which measured
parent attitudes,
beliefs, and
experiences with
adolescent
vaccines (includes
patient-provider
communication).

Intervention was
provider
recommendation
of vaccine
(provider-driven
communication).

Researchers found
that 53% of study
participants reported
collaborative
communication with
their child’s
healthcare provider.
Patients who were
least likely to report
this style of
communication were
“poor, less educated,
Spanish-speaking,
Southern, and rural”
as well as Hispanic
parents who did not
have private health
insurance.
Provider
recommendation of
vaccines increased
likelihood of parents
vaccinating their
adolescents.
Provider-driven
communication
styles were
associated with
higher rates of HPV
vaccine uptake.

“stronger beliefs
about sexual
disinhibition”. The
provider should
tailor how they
communicate their
recommendation to
fit the unique
parent- adolescent
dyad.
Health care
providers should
use collaborative
communication
with all patients
and parents as
another tool to
increase HPV
vaccination uptake.

Providers should
efficiently
communicate and
recommend HPV
vaccination.
Authors
recommended
intervention
studies be
completed to
confirm that
efficient
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North, A. L., & Niccolai,
L. M. (2016). Human
papillomavirus
vaccination requirements
in US schools:
Recommendations for
moving forward.
American Journal of
Public Health, 106(10),
1765-1770.

The purpose of
this article was to
summarize
current HPV
vaccine
requirements in
the US and to
explore pros and
cons of such
policies.

Paskett, E. D., KrokSchoen, J. L., Pennell, M.
L., Tatum, C. M., Reiter,

“To describe and
report the results
of a group-

Survey (NIS)Teen (conducted
by CDC).
National survey.
N/a. This article
is not a study; it
is a discussion
with future
recommendations
for policies to
increase HPV
vaccine series
uptake and
completion rates
in the US.

337 parents
(daughter ages 917) in

Expert
opinion.
Level VII.

No tools or
instruments used
this was not a
research study.

No interventions
completed this was
not a research
study.

Grouprandomized

Providers
completed surveys
to assess HPV

MLI. Clinic-level
focused on
creating an

Rationale for
requiring the HPV
vaccine for school
include vaccine
safety and efficacy,
possible increased
vaccine coverage,
possible reduction in
health disparities,
influence how
providers
recommend the
vaccine, “safety net”,
achieve herd
immunity, improve
public health.
Rationales against
HPV vaccine
requirements include
low acceptance rates
of the vaccine,
garnering enough
political support to
pass such
requirements,
financial burden
(private or public)
and increased
funding, other
interventions may
also provide increase
in HPV vaccination
rates.
The multi-level
intervention
increased HPV

communication
increases HPV
vaccination in
adolescents.
Healthcare
providers and
public health
officials can weigh
the pros and cons
of this discussion.
This could spark
ideas for policy
level interventions
to increase HPV
vaccine uptake
rates.

To improve HPV
vaccination rates,
multiple levels of
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P. L., Peng, J., Bernardo,
B. M., Weier, R. C.,
Richardson, M. S., &
Katz, M. L. (2016).
Results of a multilevel
intervention trial to
increase human
papillomavirus (HPV)
vaccine uptake among
adolescent girls. Cancer
Epidemiology, Biomarkers
& Prevention, 25(4), 593602.

randomized trial
(GRT) at the
county-level
testing of the
efficacy of the
MLI to improve
HPV vaccination
among this
population.”

Appalachian
Ohio. 24 clinics,
199 providers
from included
clinics.

trial. Level
II.

vaccine knowledge
and attitudes, selfefficacy to discuss
with parents and
patients about the
vaccine. Parents
completed a
telephone survey
and selfadministered
written survey.

Rahman, M., Elam, L. B.,
Balat, M. I., & Berenson,
A. (2013). Well-woman
visit of mothers and
human papillomavirus
vaccine intent and uptake
among their 9-17 year old

Researchers
aimed to identify
any association
between a
mother’s recent
attendance to her
well-woman
appointment and

1256 female
patients of
reproductive
health clinics.

Cross
sectional.
Level IV.

Questionnaire with
questions on
participant
demographics,
previous wellwoman
appointments,
knowledge of

environment
which had HPV
vaccine
information visible
and available.
Provider-level
focused on
education sessions
on the vaccine and
how to discuss the
vaccine with
parents. Parents
were given
educational
brochures and a
DVD about HPV
and the vaccine, a
magnet reminder
to complete the
vaccine series, a
CDC HPV vaccine
information
statement, and a
telephone call
from health
educators on the
HPV vaccine
(comparison group
received similar
materials and
education but on
the flu vaccine).
Self-administered
questionnaire.

vaccine series
initiation among
girls ages 9-17.
However, overall
uptake was low.

influence (ex.
Community,
policy) and
multiple elements
(ex. Automated
prompts,
reminders) within
each level should
be utilized.

The majority of
participants (78.3%)
had a well woman
exam within the last
2 years. After
adjusting for vaccine
awareness,
household income

The opportunity to
recommend and
advocate for
adolescent HPV
vaccination may
not only be at
pediatric visits, but
the mother’s
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children. Vaccine, 31(47),
5544-5548.

HPV vaccine
uptake for their
9-17-year-old
children.

HPV, and their
intent to vaccinate
their adolescent
children.

Roberts, M. C., Murphy,
T., Moss, J. L., Wheldon,
C. W., & Psek, W. (2018).
A qualitative comparative
analysis of combined state
health policies related to
human papillomavirus
vaccine uptake in the
United States. American
Journal of Public Health,
108(4), 493-499.
Sanderson, M., Canedo, J.
R., Khabele, D., Fadden,
M. K., Harris, C., Beard,
K., Burress, M.,
Pinkerton, H., Jackson, C.,
Mayo-Gamble, T.,
Hargreaves, M. K., &
Hull, P. C. (2017).
Pragmatic trial of an
intervention to increase

“To examine
how
combinations of
state policies,
rather than single
policies, are
related to uptake
of human
papillomavirus
(HPV) vaccine.”

50 states, plus
Washington DC.
United States.

Qualitative
comparative
analysis.
Level V.

Utilized data from
National
Immunization
Survey- Teen and
state/ Washington
DC policies.

Surveys completed
during other
research studies.

To report “on the
development and
effectiveness of
an intervention
aimed at
increasing HPV
vaccine uptake
among African
American and
Hispanic

305 mothers
(children ages 918 years) and
408 patients
(ages 9-18
years). Study
completed in 4
safety-net clinics
in 3 cities in
Tennessee.

Clustered,
nonrandomized
controlled
pragmatic
trial. Level
III.

Parents completed
a post-visit
questionnaire on
staff
implementation of
key study
components or
comparable
questions in the
control group.

Two provider/
staff training
sessions, provision
of patient
education
materials (video/
flyer) promoting
the HPV vaccine.

and a personal
history of an
abnormal Pap smear,
there was no
difference (between
women with a recent
well-woman exam
and women without
a recent exam) in the
intent to initiate and
complete the vaccine
series for their
daughters. There was
no association
between wellwoman exams and
the intent to start and
complete the vaccine
series in sons.
Researchers found
that there was not
one single policy
that had a great
impact on HPV
vaccine uptake.
Instead, there were
sets of policies that
consistently
increased HPV
vaccine uptake rates.
Patients in the
intervention group
were more likely to
initiate the HPV
vaccine series during
the initial visit,
though not
significantly.
Completion of the 3
dose series at 12-

annual well exam
too. Researchers
recommended
future research
study this
intervention and its
impact on HPV
vaccination uptake
rates.

Healthcare and
public health
professionals can
use this study as a
reference to
influence the
creation of state
policies
surrounding the
HPV vaccine
series.
Parent education
alone may not be
sufficient to
increase vaccine
uptake. Providers
should recommend
the vaccine series.
Authors
recommended
future research
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human papillomavirus
vaccination in safety-net
clinics. BMC Public
Health, 17(1), 158.

pediatric patients
in safety-net
clinics.”

Authors used the
Intervention
Fidelity Index to
create a summed
score of post-visit
questionnaire
answers.

Schnaith, A. M., Evans, E.
M., Vogt, C., Tinsay, A.
M., Schmidt, T. E.,
Tessier, K. M., &
Erickson, B. K. (2018).
An innovative medical
school curriculum to
address human
papillomavirus vaccine
hesitancy. Vaccine,
36(26), 3830-3835.

The purpose of
this study was to
create an
educational
curriculum for
medical students
to learn how to
communicate
with HPV
vaccine hesitant
patients and
parents.

132 medical
school students.
University of
Minnesota- Twin
Cities and Duluth
campuses.

Quasiexperimental.
Level III.

Shay, L. A., Baldwin, A.
S., Betts, A. C., Marks, E.
G., Higashi, R. T., Street
Jr, R. L., Persaud, D., &
Tiro, J. A.(2018). Parent-

Explore parentprovider
communication
of HPV vaccine
hesitancy and

43 clinic visits
(parent/
adolescent) with
unvaccinated

Qualitative.
Level VI.

Students surveys
before and after the
educational
intervention.
Questions
evaluated student
comfort level in
talking about the
HPV vaccine to
vaccine hesitant
parents and how
likely the student
was to recommend
the vaccine to these
parents.
Audio recordings
were completed
during clinic visits.
Recordings were
qualitatively coded

“A presentation on
the epidemiology,
biology, and
disease morbidity
associated with
HPV.” “A video
that teaches
specific
communication
strategies.” “Roleplaying
simulations.”

Provider
interventions with
vaccine hesitant
parents were
coded as only

month follow-up was
significantly lower
than the control
group. Providing
education materials
did not increase
likelihood of
vaccination at initial
visit or completion
of series by 12
month follow-up.
Provider
recommendation
during the initial
visit were 4x more
likely to initiate the
vaccine, but not
complete the series
by the 12-month
follow-up.
Students found the
C.A.S.E. method of
approaching vaccine
hesitant parents to be
most helpful.

study more intense
provider and staff
education, use
patient reminders,
and compare
efficacy of patient
education that
solely focuses on
HPV vaccine
instead of all
adolescent
vaccines.

37 of 43 parents
expressed HPV
vaccine hesitancy 1+
times (assertive
responses, questions,

Providers should
not acquiesce to
parental vaccine
hesitancy
immediately.

Provider education
on how to best
communicate with
HPV vaccine
hesitant parents
may help increase
providers’
confidence level.
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provider communication
of HPV vaccine hesitancy.
Pediatrics, 141(6).

HPV vaccine
uptake.

adolescent.
Dallas, Texas.

Suryadevara, M.,
Bonville, C. A., Cibula, D.
A., & Domachowske, J. B.
(2019). Cancer prevention
education for providers,
staff, parents, and teens
improves adolescent
human papillomavirus,
immunization rates. The
Journal of Pediatrics, 205,
145-152.e2.

“To develop a
program to
educate
providers, office
staff, patients,
and parents on
life-long cancer
prevention
strategies,
including the use
of human
papillomavirus
(HPV) vaccine to
improve
adolescent HPV
vaccination
rates.”

6 large pediatric
offices in
upstate New
York.

Cohort study.
Level IV.

Thomas, T. L., Strickland,
O. L., DiClemente, R.,
Higgins, M., & Haber, M.
(2012). Rural African
American parents’

“To identify
predictors of
human
papillomavirus
(HPV)

400 African
American parents
of adolescents
(ages 9-13
years). Rural

Crosssectional.
Level IV.

on how parents
verbally expressed
vaccine hesitancy.

persistence, a mix
of acquiescence
and persistence,
and only
acquiescence.

Anonymous survey
to assess provider
and staff baseline
knowledge and
beliefs on the
vaccine and cancer
prevention.
Vaccination rates
and change in rates
were calculated for
each clinic.
Authors compared
data to other New
York counties and
the state’s overall
HPV vaccination
rate at 6 and 12
months postintervention.
County/state data
retrieved using the
New York State
Immunization
Information
System.
The Health Belief
Model (HBM)
provided the
framework for this
study. Surveys

On-site education
for providers and
staff. A cancer
prevention booklet
was given to
adolescents and
their families.

Survey
completion.

& concerns). When
providers only used
persistence to
respond to hesitancy,
17/18 adolescents
were vaccinated.
When providers only
acquiesced, no
adolescents were
vaccinated.
Adolescent vaccine
initiation and series
completion rates
increased after
program
implementation.

Parents who
initially are
hesitant to
vaccinate their
child can be
influenced by
providers to
change their
minds.

Researchers
identified religious
affiliation was
associated with
parents planning to

Public health
education and
provider education
must take into
account rural

HPV vaccination
rates in adolescents
may be modestly
improved with
cancer prevention
education that is
given to providers,
office staff,
patients, and
parents.
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knowledge and decisions
about human
papillomavirus
vaccination. Journal of
Nursing Scholarship,
44(4), 358-367.
Thomas, T. L., Strickland,
O., Diclemente, R., &
Higgins, M. (2013). An
opportunity for cancer
prevention during
preadolescence and
adolescence: Stopping
human papillomavirus
(HPV)-related cancer
through HPV vaccination.
Journal of Adolescent
Health, 52(5 Suppl), S6068.

vaccination
among rural
African
American
families.”

counties in
southeastern
United States.

were anonymously
completed.

or have already
vaccinated their
child against HPV.

Researchers
aimed to identify
correlating
factors of
parental
acceptance and
refusal of the
HPV vaccine in a
rural setting.

519 parents of
adolescents (ages
9-13 years).
Rural Georgia.

Crosssectional.
Level IV.

The Health Belief
Model (HBM)
provided the
framework for this
study. Surveys
were anonymously
completed.

Survey
completion.

Victory, M., Do, T. Q. N.,
Kuo, Y. F., & Rodriguez,
A. M. (2019). Parental
knowledge gaps and
barriers for children
receiving human
papillomavirus vaccine in
the Rio Grande Valley of
Texas. Human Vaccines &
Immunotherapeutics,
15(7-8), 1678-1687.

The goal of this
study “was to
understand
parental
knowledge and
attitudes about
HPV and the
HPV vaccine as
well as child
experience with
the HPV vaccine
among medically
underserved,
economically

622 parents (of
4-th-12th
graders). Rural
Texas.

Crosssectional.
Level IV.

Parental surveys.

Survey
completion.

Researchers found
that parents who
were not African
American and were
not Baptist were two
to almost 3 times as
likely to vaccinate or
intend to vaccinate
their adolescent
against HPV.
Researchers also
found that parents
who perceived more
barriers to getting
the vaccine and
perceived fewer
benefits were more
likely to vaccinate or
intend to vaccinate
their children.
Researchers found
that 43.9% of parents
reported provider
recommendation of
the vaccine, and
32.5% of parents had
initiated the vaccine
and 18.8% fully
vaccinated their
child at the time the
study was
completed. 28.2% of
parents reported their
child initiated getting

African American
parents’ religious
beliefs, knowledge
on HPV, and
attitudes on HPV
and the vaccine.
When providing
education on the
HPV vaccination
in rural areas, the
healthcare provider
should relay
information in
“context of the
patients’ cultural
values, geographic
location, and
economic
situation.”
Highlighting the
benefits of cancer
prevention can also
help to increase
vaccine uptake.
Parents and
children still have
gaps in
understanding the
HPV vaccine.
There are still gaps
between male and
female vaccination
rates, as well as a
lack in provider
recommendation.
Researchers
recommend
educational
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disadvantaged
population.”

Winer, R., Gonzales, A.,
Noonan, C., & Buchwald,
D. (2016). A clusterrandomized trial to
evaluate a motherdaughter dyadic
educational intervention
for increasing HPV
vaccination coverage in
American Indian girls.
Journal of Community
Health, 41(2), 274-281.

Evaluate if
educational
presentations on
HPV to
American Indian
mothers
impacted HPV
vaccination rates
in their
adolescent
daughters.

97 Hopi mothers/
female guardians
and daughters
(ages 9-12
years). Hopi
Reservation.

Clusterrandomized
intervention.
Level II.

Baseline surveys
taken prior to
intervention. 11month follow-up
survey to evaluate
daughters’ HPV
vaccine uptake
status.

Mother-daughter
dinners with
educational
presentations for
mothers on HPV
(intervention
group) or juvenile
diabetes (control).

the vaccine. Parents
reported that
scheduling conflicts
with school or work,
as well as no
healthcare provider
recommendation,
were barriers to
vaccinating.
By the 11-month
follow-up survey,
intervention and
control groups had
similar HPV vaccine
uptake rates. Those
adolescents who had
not started the
vaccine series prior
to the study, girls
whose mothers had
HPV education were
more likely to start
the vaccine series
themselves than girls
whose mothers were
in the control group.

interventions
(especially for men
and minorities) to
increase
understanding and
awareness on HPV
related cancers and
the vaccine.
Adolescent girls
whose mothers
receive education
on the HPV
vaccine may be
more likely to
initiate the vaccine
series than girls
whose mothers do
not receive
education on the
HPV vaccine.
Providing
education on the
HPV vaccine to
mothers may
increase vaccine
uptake in
daughters, but this
study suggests the
rate increase is
limited.

